SENS-AI
ACT Trading Statement Bearish

AFROCENTRIC INVESTMENT CORPORATION LIMITED - Trading statement for the year ended 31 December 2025

AfroCentric Investment Corporation Limited
Full analysis

What this filing means

AfroCentric expects a 100%+ surge in headline earnings despite a massive statutory loss of 150-153 cents per share due to heavy impairments and lost Bonitas contracts.

AfroCentric is making more money from its day-to-day operations (Headline Earnings), but it has to write down the value of its business by a huge amount. This is because it lost some big contracts with Bonitas and is selling off a struggling division called Activo.

Bull case

  • Headline Earnings Per Share (HEPS) is expected to rise by more than 100% to between 13.5 and 14.25 cents.
  • Strong operational resilience in local administration and managed care, supported by higher earnings from capitation lines.
  • Strategic classification of the underperforming Activo asset as 'Held For Sale' to streamline the group structure.

Bear case

  • Projected loss per share of 150-153 cents represents a massive deterioration from the 14.96 cents loss in the prior period.
  • Impairment losses triggered by the loss of material Bonitas contracts for Medscheme starting June 2026.
  • Extremely high Price/Book ratio of 30.94x despite negative EPS and significant revenue risk.
  • The underlying financial data is unaudited, increasing the risk of further adjustments.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

AfroCentric's trading statement presents a sharp divide between improved core operational performance (HEPS up 100%+) and a catastrophic statutory loss of 150-153 cents per share. While the bull case rests on the resilience of the administration and managed care segments, the bear case is heavily fortified by the R1.50+ per share loss driven by impairments and the looming loss of material Bonitas contracts in 2026. The market's positive reaction likely reflects relief at the Activo disposal, but the long-term revenue cliff at Medscheme remains a major fundamental overhang. Signal-to-Price Note: The price is up 9.82% despite the massive statutory loss. This is most likely a 'Relief Rally' because the market is rewarding the transparency regarding the Activo disposal and the resilience of the core HEPS, despite the non-cash impairment charges.

High-risk turnaround play. Watch for the 3 March results to confirm the scale of Medscheme revenue loss before committing fresh capital.

Decision framework

Current stance: Lean Bull

Key drivers

  • Headline Earnings Per Share (HEPS) is expected to rise by more than 100% to between 13.5 and 14.25 cents.
  • Strong operational resilience in local administration and managed care, supported by higher earnings from capitation lines.
  • Strategic classification of the underperforming Activo asset as 'Held For Sale' to streamline the group structure.

Key risks

  • Projected loss per share of 150-153 cents represents a massive deterioration from the 14.96 cents loss in the prior period.
  • Impairment losses triggered by the loss of material Bonitas contracts for Medscheme starting June 2026.
  • Extremely high Price/Book ratio of 30.94x despite negative EPS and significant revenue risk.

What would change the view

  • Forward guidance is cut or withdrawn in the next update.
  • Cash-flow conversion deteriorates relative to reported earnings.
  • Positive thesis fails to hold through the next reporting window.

Evidence from the filing

  • The Group forecasts a substantial increase of more than 100% in Headline Earnings Per Share (HEPS)

    “Headline earnings per share for the current reporting period is expected to be between 13.5 cents and 14.25 cents reflecting an increase of more than 100% in comparison to the headline profit per share of 3.80 cent in the previous corresponding period (as previously reported).”

  • This strong improvement in headline earnings is directly attributable to the resilient operational performance

    “The improvement in headline earnings is attributable to the resilient operational performance of the local administration and managed care operations, as well as, sustained public market retail performance.”

  • Classification of Activo as 'Held For Sale' indicates a strategic move to divest

    “The operational underperformance of Activo which has since been classified as Held For Sale.”

  • The projected loss per share is expected to be between 150 cents and 153 cents

    “Loss per share for the current reporting period is expected to be between 150 cents and 153 cents reflecting a decrease of more than 100% in comparison to the loss of 14.96 cents per share in the previous corresponding period (as previously reported)”

  • Significant lower forecast earnings following Bonitas' announcement

    “lower forecast earnings attributable to several Service Cluster entities, including Medscheme, following Bonitas' announcement of 29 January awarding several material contracts to other service providers from 1 June 2026”

  • The financial information has not been audited

    “The financial information on which this trading statement is based has not been audited, reviewed, or reported on by AfroCentric's external auditors.”
Category
Trading Statement
Published
Mar 2, 2026

More on AfroCentric Investment Corporation Limited

AfroCentric Investment Corporation Limited (ACT) share price All AfroCentric Investment Corporation Limited SENS announcements

Related filings